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Background: In this study we implemented and developed state-of-the-art machine learning (ML) and natural
language processing (NLP) technologies and built a computerized algorithm for medication reconciliation. Our
specific aims are: (1) to develop a computerized algorithm for medication discrepancy detection between patients’
discharge prescriptions (structured data) and medications documented in free-text clinical notes (unstructured data);
and (2) to assess the performance of the algorithm on real-world medication reconciliation data.
Methods: We collected clinical notes and discharge prescription lists for all 271 patients enrolled in the Complex
Care Medical Home Program at Cincinnati Children’s Hospital Medical Center between 1/1/2010 and 12/31/2013.
A double-annotated, gold-standard set of medication reconciliation data was created for this collection. We then
developed a hybrid algorithm consisting of three processes: (1) a ML algorithm to identify medication entities
from clinical notes, (2) a rule-based method to link medication names with their attributes, and (3) a NLP-based,
hybrid approach to match medications with structured prescriptions in order to detect medication discrepancies.
The performance was validated on the gold-standard medication reconciliation data, where precision (P), recall
(R), F-value (F) and workload were assessed.
Results: The hybrid algorithm achieved 95.0%/91.6%/93.3% of P/R/F on medication entity detection and 98.7%/
99.4%/99.1% of P/R/F on attribute linkage. The medication matching achieved 92.4%/90.7%/91.5% (P/R/F) on
identifying matched medications in the gold-standard and 88.6%/82.5%/85.5% (P/R/F) on discrepant medications. By
combining all processes, the algorithm achieved 92.4%/90.7%/91.5% (P/R/F) and 71.5%/65.2%/68.2% (P/R/F) on
identifying the matched and the discrepant medications, respectively. The error analysis on algorithm outputs
identified challenges to be addressed in order to improve medication discrepancy detection.
Conclusion: By leveraging ML and NLP technologies, an end-to-end, computerized algorithm achieves promising
outcome in reconciling medications between clinical notes and discharge prescriptions.
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language processingBackground
Several studies have reported the prevalence of the
medication discrepancy problem in adult patients [1-3].
According to the most conservative estimate in the lit-
erature, about half of the adult and geriatric patients in
primary care had at least one medication discrepancy
[1,2]. The studies investigating the harm associated with* Correspondence: Yizhao.Ni@cchmc.org
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tentional discrepancies upon hospital discharge had the
potential to cause a significant clinical impact [1,3]. To
improve medication accuracies, medication reconcili-
ation, the process of comparing a patient’s medication
orders to all medications the patient has been taking, is
frequently utilized to detect medication discrepancies
and then communicate the newly reconciled list to the
patient and the clinical care providers [4,5]. In recent
years, medication reconciliation has become common
practice to prevent medication-related errors and is nowis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
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institutions [1,6-21].
Despite its wide acceptance, medication reconciliation
is inadequately performed in current clinical practice.
Sustaining effective and accurate reconciliation remains
challenging [22-27]. Literature studies identified various
factors contributing to the inadequacy of medication
reconciliation, among which two key findings are com-
plexity of the reconciliation process and lack of time in a
busy clinical practice setting [22,26,27]. In addition,
many respondents noted that physicians frequently used
free-text medication lists in clinical notes instead of using
computerized provider order entry systems [21,28,29].
The free-text medication data is inaccessible to computer-
ized reconciliation applications that rely on structured
medication information, which further increases the medi-
cation reconciliation burden. As such, accurate and timely
reconciliation during care transitions poses significant
challenges to clinical care providers, and it has received
the attention of both the World Health Organization and
the Institute for Healthcare Improvement [30,31].
Initial efforts have been made to improve the efficacy
of the medication reconciliation process, but most of
them rely on manual vigilance and, subsequently, are
prone to clinician fatigue and human errors [9,11,13,14].
Only a handful of studies have investigated automated
or semi-automated approaches: Hassan et al. attempted
to identify missing medications between patients’ medi-
cation lists using a collaborative filtering method and
Silva et al. proposed a natural language processing-
(NLP) based approach to reconcile medications manu-
ally identified from clinical notes to structured prescrip-
tion lists [17,18]. A similar study was presented by
Schnipper et al. on reconciling a patient’s preadmission
prescription list with the discharge medication regimen
in the Electronic Health Record (EHR) using a commer-
cialized clinical decision support tool [19]. However,
previous studies only reconciled medications between
structured prescription lists; the challenges of reconcili-
ation on free-text clinical notes remained unsolved.
The recall in identifying matched and discrepant medi-
cations plateaued at less than 50% on the synthetic data
and degraded when the approaches were evaluated in
real-world scenarios (e.g. 23.4% recall on the matched
medications reported in the work of Schnipper et al.)
[17,19]. To reconcile medications documented in free-
text clinical narratives, Cimino et al. used an external
NLP system to parse clinical notes and identify medi-
cation terms, which were then matched to medication
categories using a hard-coded medical entities diction-
ary [20]. However, the study was evaluated on only 17
patient records. Further development and evaluation
of automated medication reconciliation is therefore
required.To address these barriers and fill the gap in know-
ledge, we developed and implemented state-of-the-art
machine learning (ML) and NLP technologies and built
a computerized algorithm for medication reconciliation.
Our specific aims are: (1) to develop a hybrid automated
algorithm for discrepancy detection between patients’
discharge prescriptions (structured data) and medica-
tions documented in free-text clinical notes (unstruc-
tured data); and (2) to assess the performance of the
algorithm on gold-standard-based real-world medication
reconciliation data. The overall objective is to develop an
end-to-end computerized algorithm to identify potential
medication discrepancies to reduce the pool of medications
for manual reconciliation. Leveraging a double-annotated,
physician-validated gold-standard set of medication recon-
ciliation data, we demonstrated that an EHR-based com-
puterized algorithm could improve medication discrepancy
identification and substantially reduce the effort of manual
reconciliation.
Methods
In this study we focused on pediatric in patients en-
rolled in the Complex Care Medical Home Program
(CCMHP) at Cincinnati Children’s Hospital Medical
Center (CCHMC) between 1/1/2010 and 12/31/2013.
Approval of ethics for this study was given by the
CCHMC institutional review board (study ID: 2013–4241)
and a waiver of consent was authorized.
Data sources
CCMHP serves a small population of patients with
multiple chronic illnesses and dependence on medical
technologies such as feeding tubes or artificial airways.
The target population is an ideal group for medication
reconciliation study because the patients usually have
long medication lists, multiple care providers, and fre-
quent transition between the hospital, clinic, and home
care settings. Based on the pre-study communication
with the physicians, we focused on patient discharges
where two types of clinical notes (unstructured data)
could be compared to the discharge prescription list
(structured data). Our motivation arises from the fact
that the medications documented in the free-text notes
might be missed during the order-entry process. As
such, the computerized reconciliation between the clinical
notes and the prescription list could alert prescribers to
medication discrepancies that would not otherwise be dis-
covered. The clinical notes being reconciled included: (1)
problem overview notes, which, by common practice in
the CCMHP, described each patient’s problem and the
corresponding plan of care including medications, and (2)
discharge summaries, which described the post-discharge
therapy including medications. Figure 1 shows an over-
view note, a discharge summary, and a prescription list
Figure 1 The example overview note (a), discharge summary (b) and discharge prescription list (c) for an encounter. The medication information
identified by the annotators is highlighted in clinical notes.
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clinical notes were mentioned in free text (Figure 1a and
b). The information of discharge prescriptions was stored
in multiple data fields in the EHR database (Figure 1c).We used SQL queries to extract all fields associated with
discharge prescriptions, including patient ID and encoun-
ter ID in which a prescription was ordered, prescription
name and generic name, instruction, route, frequency,
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each encounter, we extracted the overview notes associ-
ated with a patient’s problems that remained active at the
time of discharge, suggesting that the patient should still
take the medications for these problems. We also ex-
tracted all discharge summaries and the corresponding
discharge prescription lists for the encounters. In total, we
collected 4025 overview notes, 1717 discharge summaries
and 975 prescription lists for all 975 inpatient encounters
(271 complex care patients) during the study period. We
manually reconciled all 4025 overview notes against the
975 prescription lists. Because discharge summaries are
much longer and a comprehensive reconciliation of them
was not feasible, we randomly sampled 300 (17.5%) dis-
charge summaries and reconciled them against their
corresponding prescription lists.
Gold-standard medication reconciliation data
Medication matches and discrepancies between the clin-
ical notes and the prescription lists were double annotated
by two annotators using the Knowtator plug-in for Pro-
tégé [32,33]. Both annotators are English speakers (one
clinical research nurse and one with an associate of ap-
plied science degree in health information science), with
at least one year of clinical text annotation experience.
Following the guidelines developed by the physicians, they
first identified medication entities (e.g. medication name)
from clinical notes and linked the attributes (amount, dos-
age, duration, form, frequency, route, and strength,
highlighted in Figure 1a and b) to the corresponding
medication names. Then they matched the identified med-
ications with the prescriptions in the discharge list: (1) ifDetect medication

























Figure 2 The architecture of the proposed automated medication discrepa
processes. Bullet A-C represent the outputs of the processes that were eva
entities mentioned in the clinical notes and that had matches in the presc
entities mentioned in the clinical notes but were missed in the prescription
the notes and the list.the medication entities were identical between the notes
and the prescriptions, they labeled them as “matched”; (2)
if a medication in the notes was missed in the prescription
list (e.g. Bullet one in Figure 1) or its medication attributes
were not consistent (e.g. Bullet two), they labeled it as
“discrepant”. Since a discharge prescription list also con-
tained medications prescribed by other health care pro-
viders (documented upon hospital admission) which were
not mentioned in the collected clinical notes, we did not
reconcile medications in the reverse direction (matching
discharge prescriptions with medications in the clinical
notes) to avoid false positives of discrepant medications.
After the annotation process, differences between the
annotators’ decisions were resolved under the supervi-
sion of an annotation manager (bachelor’s degree with
more than four years of experience in clinical text an-
notation) and the inter-annotator agreement (IAA) was
calculated using F-value to measure the agreement [34].
The consensus of the medication entities identified in the
clinical notes, the associations between the attributes and
the medication names, and the medication matches and
discrepancies labeled by the annotators were then used
as the gold-standard data to train and evaluate the au-
tomated algorithm.
Automated medication discrepancy detection
The proposed medication discrepancy detection algorithm
is diagramed in Figure 2. Given the clinical notes and the
prescription list for an encounter, the algorithm first iden-
tified all medications and attributes from the clinical notes
using ML techniques (Process 1 in Figure 2). It then linked
the attributes to the corresponding medication names onication
d their
tes
NLP - and information
extraction-based
medication matching
Output of discrepancy detection
1. matched medication list*













ncy detection algorithm. Bullet 1–3 represent the three algorithm
luated in the study. *“Matched medication list” includes the medication
ription list. **“Discrepant medication list” includes the medication
list, or had medication attributes that were not consistent between
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brid algorithm compared the identified medication entities
with the prescriptions in the prescription list and returned
a list of medications/attributes with associated “matched”
or “discrepant” labels (Process 3).
Medication entity detection and attribute linkage
Medication entity detection, including medication name
and attribute detection, was designed in-house based on
the MALLET conditional random field (CRF) package
[35,36]. Details of the medication entity detection process
can be found in our earlier publications [37-39]. The
process first tokenized and parsed the clinical notes with
an in-house tokenizer and part-of-speech tagger. For each
word, the token-level properties (e.g. capitalization and
punctuation), the context (e.g. tokens before and after the
studied token) and the part-of-speech tags were then used
as text features in the CRF model. The term-level medica-
tion information, including the Concept Unique Identifiers
from the Universal Medical Language System, Systema-
tized Nomenclature of Medicine – Clinical Terms codes,
and the clinical drug codes of RxNorm, were also identi-
fied from the text using the clinical Text Analysis and
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Figure 3 The diagram of the medication matching process.features in the CRF model [40]. Finally, the CRF model
was trained on a set of clinical notes with gold-standard
annotations (Figure 1) before executing entity detection
on the held out test set (see “Experiments” section for the
detailed setup of the experiments).
Attribute linkage applied a rule-based method to associ-
ate the identified attributes to the medication names [37].
The pseudo-code of the algorithm is presented in Table
A.1 (Additional file 1). In summary, each identified attri-
bute was linked to the closest medication name in abso-
lute character distance, whether the medication preceded
or followed the attribute.
Medication matching
Building on our previous experience in clinical trial-patient
matching, the medication matching customized the
NLP-based method in the literature and extended it with
information extraction techniques [18,41]. The process
reconciled each medication-prescription pairs with four
steps, which are diagramed in Figure 3.
The first step (Bullet 1 in Figure 3) was a string-based
regular expression matching. If the medication in the clin-
ical notes was identical to, or a substring of, a prescription
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same step was also applied to compare the medication
with the generic name of the prescription. If the exact
match was not found, the mention of the medications (e.g.
“ipratropium” and “albuterol” in “ipratropium 500 mg/
2.5 ml – albuterol 2.5 mg/0.5 ml nebulizer solution”) was
extracted from the medication identified in the notes and
the prescription in the list. If these terms co-occurred in a
medication-prescription pair previously observed in the
training set, the algorithm returned “matched.” This second
step utilizes the medication-prescription pairs in the train-
ing set for approximate term matching, which enables the
algorithm to learn from previously collected information in
practice. Step three was similar to step two but used the
RxNorm dictionary to find medication synonyms [42]. If
the medication terms co-occurred in the same RxNorm de-
scription (e.g. “diastat” and “diazepam” co-occurred in the
description of RxNorm code 2052646 “diazepam rectal gel
[diastat]”), implying that they were probable synonyms, the
algorithm returned “matched.” The algorithm also utilized
the RxNorm dictionary to match trade names of the medi-
cations (Step 4). In this step, both the medication and the
prescription were mapped to the RxNorm codes using in-
formation extraction techniques. If one code was a trade
name of the other, the algorithm returned “matched.” If no
match was found from the above steps, the algorithm
returned “discrepant.”
For each medication identified in the clinical notes, the
matching process compared it with all prescriptions in a
corresponding prescription list. If a matched prescription
was found, the algorithm further compared the associated
attributes with the prescription attributes using string-
based regular expressions and output “matched” or
“discrepant” label for each attribute.Table 1 Descriptive statistics of the annotated clinical notes




Category Discr Match All Discr
Medication name 1116 3873 4989 24
Amount 169 1270 1439 47
Dosage 106 857 963 26
Duration 4 16 20 0
Form 36 1246 1282 6
Frequency 410 2742 3152 38
Route 48 443 491 42
Strength 142 1281 1423 4
Overall 2031 11728 13759 187
“Discr” column shows the number of discrepant entities and “Match” the number oExperiments
Evaluation metrics
We used three standard NLP metrics to measure perform-
ance: precision = True Positive/(True Positive + False Posi-
tive), recall = True Positive/(True Positive + False Negative),
and F-value = (2*P*R)/(P + R).
The experiments were conducted in a ten-fold cross
validation setting, where the gold-standard data was di-
vided at the encounter level and randomly split into ten
rotating subsets – nine for training and one for testing
at each run.
Performance tests of medication discrepancy detection
We evaluated the performances of the three processes
individually and in combination to assess the error
propagation through the algorithm pipeline. The outputs
of the three processes are depicted in Figure 2 (Bullet A-C).
We first evaluated the performances individually. The
CRF-based entity detection algorithm was trained and
tested in the ten-fold cross validation setting. To ensure
the unbiased assessment of the algorithm, in each fold
we performed a stratified random sampling based on
numbers of clinical notes for each patient to split the
data into training and test sets. To assess the attribute
linkage process, the gold-standard medication and attri-
bute annotations were fed into the algorithm and the
performance was evaluated against the gold-standard
medication-attribute associations. The same setting was
applied when assessing the medication matching
process, where the performances were presented for
gold-standard matched and discrepant medications re-
spectively. A true positive of a matched medication was
determined if and only if the algorithm returned a




Match All Discr Match All
2935 2959 1140 6808 7968
1937 1984 216 3207 3423
711 737 132 1568 1700
70 70 4 86 90
2434 2440 42 3680 3722
2635 2673 448 5377 5825
2836 2878 90 3279 3369
2092 2096 146 3373 3519
15650 15837 2218 27378 29596
f matched entities.
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lowing the literature, the evaluations on the first two
processes were assessed at the token level, while the
evaluation on medication matching was assessed at the
span level to ensure that each medication and its attri-
butes were evaluated only once [37,39].
We then evaluated the performances that cumulatively
integrated the processes. The output of the medication
entity detector (Bullet A in Figure 2) was the input of
the attribute linkage algorithm instead of the gold-















































Figure 4 The overall inter-annotator agreements (IAAs; F-value) for overvie
categories are also presented (b and c).and the associated attributes used in medication match-
ing also came from the predictions of the first two pro-
cesses (Bullet B in Figure 2). Since the objective of this
study was to develop a high-recall algorithm for detect-
ing discrepant medications, we also analyzed the recall
propagation on discrepant medications to assess the in-
fluence of each algorithm component on discrepant
medication detection.
In both experiments no manual customizations were
made to the automated algorithm to avoid over-fitting
the current data sets. The entity detection and theategories
ategories
w notes and discharge summaries (a). The IAAs on individual entity
Table 2 Performance of the entity detection process
Process Medication entity detection
Category P [%] R [%] F [%]
Medication name 92.3 88.6 90.4
Amount 94.8 90.7 92.7
Dosage 90.9 87.9 89.4
Duration 73.5 43.2 54.5
Form 95.0 93.0 94.0
Frequency 94.0 89.5 91.7
Route 95.5 94.0 94.7
Strength 95.0 94.9 95.0
Overall 95.0 91.6 93.3
P indicates precision; R recall; F F-value.
Table 3 Performance of the attribute linkage process
Process Attribute linkage Ent. Det. + Att. Link.
Category P [%] R [%] F [%] P [%] R [%] F [%]
Amount 97.5 99.3 98.4 92.8 89.5 91.1
Dosage 97.8 99.5 98.7 87.9 86.1 87.0
Duration 94.3 96.6 95.4 73.4 42.1 53.5
Form 99.2 99.6 99.4 94.2 91.9 93.0
Frequency 99.0 99.2 99.1 92.4 87.6 89.9
Route 99.3 99.3 99.3 94.5 92.1 93.3
Strength 99.0 99.8 99.4 93.9 93.3 93.6
Overall 98.7 99.4 99.1 92.8 89.6 91.2
P indicates precision; R recall; F F-value.
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the data that was never part of the test set in each run
of the experiments.
Results
Descriptive statistics of gold-standard data
Table 1 shows the descriptive statistics of the annotated
corpus, including the number of patients, encounters,
clinical notes and the numbers of matched and discrep-
ant entities for each entity category. The annotators
identified 29,596 entities from the clinical notes, where
the discharge summaries had higher entity density than
the overview notes (53 versus three entities per note).
All medication attributes had similar frequencies except
dosage and duration. The corpus had 7.5% of discrepant
medications and attributes, scattered across 164 patients
(60.5%) and 423 encounters (43.4%).
Figure 4 shows the IAAs between the annotators and
between the annotators and the consensus. The IAAs
were computed for overall (Figure 4a) and for each
medication entity category per note type (Figure 4b
and c). We observed that the IAAs were generally
lower on the overview notes due to irregular medica-
tion expressions made by physicians. For instance, in
certain cases the medication “Augmentin” was written
as “abx” (antibiotics) in the clinical notes but “amoxi-
cillin clavulanate” in the prescription list, making it
difficult for annotator 2 (with less clinical experience)
to identify the match. The IAAs on duration were also
low due to the frequency of this category (Table 1).
Nevertheless, the consensus made under the supervision
of the annotation manager still assured the high quality of
the gold-standard set, which was evident by the high IAAs
between the annotator 1 (clinical research nurse) and the
consensus (Figure 4a).
Medication entity detection and attribute linkage
Table 2 shows the performances of the medication entity
detection process. The ML-based algorithm achieved an
overall F-value of 93.3% (95.0% precision, 91.6% recall).
Most of the entity categories achieved greater than 90%
F-values. The performance was low on “duration” because
of the limited amount of training data in this category
(Table 1).
The rule-based attribute linkage achieved the overall
F-value of 99.1% (precision 98.7%, recall 99.4%, Table 3).
When combining the entity detection and the attribute
linkage processes (processes 1 and 2 in Figure 2), the
propagated F-value was 91.2% (precision 92.8%, recall
89.6%) across all attributes.
Medication matching
Table 4 shows the performances of the hybrid medica-
tion matching on gold-standard matched and discrepantmedications respectively. The medication name match-
ing achieved 97.5% F-value on matched medications and
85.5% on discrepant medications. The attribute match-
ing achieved similar performances on matched categor-
ies, while the performances were reduced on discrepant
categories. The overall F-value on the matched categor-
ies was 95.3% (precision 98.1%, recall 92.8%), higher
than 64.7% F-value on the discrepant categories (preci-
sion 53.4%, recall 81.8%).
By integrating all three processes, the proposed medica-
tion discrepancy detection algorithm (Figure 2) achieved
92.4%/90.7%/91.5% (precision/recall/F-value) on matching
names of matched medications and 71.5%/65.2%/68.2%
(precision/recall/F-value) on discrepant medications. The
overall performance was 95.6%/86.6%/91.0% (precision/
recall/F-value) on the matched categories and 42.2%/
64.6%/51.0% (precision/recall/F-value) on the discrepant
categories.
Recall propagation on discrepant medications
To assess the influence of each algorithm component on
discrepant medication detection, we plotted in Figure 5
the recall propagation during the three processes. The
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the overview notes and the discharge summaries re-
spectively. For discrepant medications in the discharge
summaries, the proposed algorithm achieved a 100% re-
call on entity detection and an overall recall of 88.0%
after medication matching. The performance was lower
on the overview notes, with 82.3% on entity detection
and 64.8% after medication matching. Since the attribute
linkage process only linked the attributes to the identi-
fied medication names, it did not influence the recall of
medication name detection (i.e. recall = 100%).
Discussion
Algorithm performance
We evaluated the three processes of automated medica-
tion discrepancy detection individually and in combin-
ation using double-annotated, gold-standard medication
reconciliation data. The ML-based medication entity de-
tection showed good capability in identifying medication
names and attributes and achieved an F-value of 93.3%
(Table 2). The results of attribute linkage suggested that
even a relatively rudimentary, rule-based algorithm
could yield high performance (overall F-value 99.1%,
Table 3). The hybrid medication matching also achieved
reasonable recalls on medication name matching (98.2%
on matched medications and 82.5% on discrepant medi-
cations, Table 4), suggesting the effectiveness of the NLP
and information extraction techniques used such as the
RxNorm dictionary mapping. The attribute matching
achieved similar performances on the matched categories.
The performances were reduced on matching discrepant
attributes, resulting in a lower overall performance on the
discrepant categories.
By integrating the three processes, the proposed algo-
rithm achieved a much improved recall (90.7%/65.2% on
matched/discrepant medications, Table 4) over the re-
calls reported in the literature (e.g. 23.4% on matchedTable 4 Performance of the medication matching process
Process Medication matching
Matched Discrepant
Category P [%] R [%] F [%] P [%] R [%]
Medication name 96.8 98.2 97.5 88.6 82.5
Amount 98.8 91.7 95.1 39.8 82.6
Dosage 97.8 90.2 93.9 41.2 77.4
Duration 98.6 82.9 90.1 17.6 75.0
Form 99.4 90.8 95.0 8.2 61.7
Frequency 98.3 83.0 90.0 30.0 83.0
Route 99.7 90.1 94.7 19.7 89.5
Strength 99.5 93.9 96.6 40.0 89.5
Overall 98.1 92.8 95.3 53.4 81.8
P indicates precision; R recall; F F-value.medications reported in the work of Schnipper et al.
[19]), while keeping the precision at a manageable level
(92.4%/71.5% on matched/discrepant medications). The
recall propagation (Figure 5) showed that both the entity
detection and medication matching processes contrib-
uted to the loss of detection on discrepant medications;
therefore, further refinements in these components are
required to improve medication discrepancy detection.
In addition, the algorithm achieved better recalls on de-
tecting discrepant medications in the discharge sum-
maries. This is because the institutional EHR system
contains a smart list function to facilitate medication
entry on discharge summaries, where the physicians
could directly pull structured medications from a patient’s
medication list, resulting in more controlled vocabularies
in the discharge summaries. The observation suggests that
encouraging physicians to utilize structured medication
inputs in the clinical workflow could benefit computerized
medication reconciliation.Error analysis, limitations and future work
Since the study focused on detecting discrepant medica-
tions, we performed error analysis by reviewing all false
negatives made by the algorithm (i.e. discrepant medica-
tions identified by the annotators but missed by the al-
gorithm). The hybrid algorithm made 397 errors, which
were grouped into six categories in Table 5. Approxi-
mately 68% of the errors (cause 1) were ascribed to the
omission of medication entities by the entity detection
algorithm due to abbreviations used in the clinical notes
(e.g. “abx” for “antibiotics” and “NS” for “normal saline”),
misspellings (e.g. misspelled “Affrin” as “Afrin” and “Nutro-
pin” as “Neutropen”) and uncommon medication names
(e.g. “Pedia Sure”). This observation suggests the limitation
of the data-driven ML-based algorithms. In our future
work, we will investigate using NLP-based pre-processingEnt. Det. + Att. Link. + Med. Mat.
Matched Discrepant
F [%] P [%] R [%] F [%] P [%] R [%] F [%]
85.5 92.4 90.7 91.5 71.5 65.2 68.2
53.7 98.4 86.3 92.0 34.2 68.7 45.7
53.8 97.2 83.0 89.6 29.1 54.3 37.9
28.6 100 40.5 57.6 2.2 9.1 3.5
14.4 99.3 86.6 92.5 5.3 39.2 9.4
44.1 98.0 77.0 86.2 25.1 68.6 36.8
32.3 99.4 86.3 92.4 16.9 72.8 27.4
55.3 99.2 89.3 94.0 30.1 76.6 43.2
64.7 95.9 86.6 91.0 42.2 64.6 51.0
Recall [%]
Figure 5 The recalls of medication name detection on
discrepant medications.
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they improve the accuracy in medication detection.
Another set of errors (cause 2 and 3) was caused by
the confusion between similar medication names (e.g.
match the medication “albuterol” to “ipratropium albute-
rol”). This is because the current medication matching
algorithm uses “bag-of-words” patterns, which limits its
ability in accurately matching combination medications.
To alleviate this problem, we will extend the pattern set
to “bag-of-phrases” in the algorithm in our future study.
In addition, we observed that the annotators tended to
determine a medication-prescription pair as discrepant
even if the medication was the same but with a different
route (e.g. oral route vs. rectal route). This caused an-
other 6% of false negatives (cause 4) because the match-
ing algorithm processed medication names and their
attributes separately. In the future we will add this
knowledge-based rule in the algorithm. Additional rules
are also required to tune the RxNorm dictionary map-
ping to reduce inappropriate matches that would cause
unexpected errors (cause 5).
There are limitations of our study. One limitation is that
the performance of attribute matching is still low because
some attributes were embedded in the context that could
be difficult to understand by the current algorithm. For in-
stance, “Baclofen 5 mg tab po bid”, “Baclofen 5 mg tab 1
tab po at 6 AM, 1 tab at 2 PM” and “Baclofen 10 mg tab”Table 5 False negative errors made by the medication discrep
Cause of false negative errors identified by the chart review
1. The medication was omitted by the medication entity detection algorithm
2. The medication was matched to a wrong medication due to similar medic
3. The prescription contains more ingredients than the medication in the clin
albuterol)
4. The medication in the clinical note was matched to a correct prescription
had a different route (e.g. oral route vs. rectal route)
5. The medication and the prescription names co-occurred in the same RxNo
(e.g. “glycerin” and “polyethylene glycol” co-occurred in the RxNorm descr
6. Other reasonsin the clinical notes suggested the same amount (10 mg)
of Baclofen for treatment. However, since the algorithm
could not analyze the semantics in the context, it failed to
match the first two cases with the correct amount in the
prescription list. The same failures were also observed on
frequency and dosage, such as identifying “AM” and “PM”
in “taking sucralfate 2 ml AM and 2 ml PM” as frequency
but failing to match it to “twice a day” in the prescription
list. In our future work we will apply advanced NLP and
knowledge-based algorithms to account for the rich se-
mantic context and high variance to improve the accuracy
of attribute matching.
Another limitation of the study is that its evaluation is
restricted to retrospective data. The prototype needs to be
transferred to a production environment to adequately es-
timate the practicality of automated medication discrep-
ancy detection. Finally, the patient population investigated
in the study usually has long medication lists documented
in clinical notes, providing a potentially more suitable
foundation for medication entity and discrepancy detec-
tion algorithms. To study its generalizability, we plan to
test the algorithm on a more diversified patient population
(e.g., patients in general care settings), multiple institu-
tions, and clinical data under different formats (e.g. clinical
record formats used in different vendors’ EHR products).
Conclusion
By leveraging ML and NLP technologies, we developed
and implemented an end-to-end hybrid algorithm for
reconciling medications between free-text clinical notes
(unstructured data) and discharge prescription lists
(structured data). In a double-annotated, gold-standard
based evaluation of real-world medication reconciliation
data, the proposed algorithm showed good capability in
medication entity detection, attribute linkage and medica-
tion matching. The algorithm achieved 92.4%/90.7%/
91.5% (precision/recall/F-value) on identifying matched
medications in the gold-standard and 71.5%/65.2%/68.2%
(precision/recall/F-value) on discrepant medications. Fur-
ther refinements in the algorithm are required to increase
the recall in identifying discrepant medications. However,ancy detection algorithm
Error [%]
68.0%
ation names (e.g. methylprednisolone and prednisolone) 9.1%
ical note or vice versa (e.g. albuterol vs. ipratropium 6.3%
(e.g. matching diastat to diazepam) but the prescription 6.0%
rm description as ingredients rather than synonyms
iption of “artificial tears”)
4.8%
5.8%
Li et al. BMC Medical Informatics and Decision Making  (2015) 15:37 Page 11 of 12even at this early stage of development, automated medi-
cation discrepancy detection shows a promising outcome
in assisting medication reconciliation. Consequently, we
hypothesize that the computerized algorithm, when trans-
ferred to the production environment, will have potential
for significant impact in reduction of effort for conducting
medication reconciliation in the clinical practice setting.
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